Daxor to Showcase Portable Blood Volume Analyzer at ACC.26, Highlighting Clinical Outcomes and Reduced Readmissions

Daxor Corporation will showcase its new, portable Blood Volume Analyzer (BVA) at ACC.26. The BVA provides accurate blood volume measurement, replacing subjective guesswork with definitive data, and has been shown to reduce heart failure readmissions by 56% and mortality by 82%. The company will demonstrate the technology at Booth #1557, highlighting its potential to scale across inpatient and outpatient care environments.